ClinicalTrials.govpublic full text
Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL
peripheral t cell lymphoma, allogeneic peripheral blood stem cell transplantation, high-risk, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 981631
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.